BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7616537)

  • 1. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis.
    Evans JP; Burke W; Chen R; Bennett RL; Schmidt RA; Dellinger EP; Kimmey M; Crispin D; Brentnall TA; Byrd DR
    J Med Genet; 1995 May; 32(5):330-5. PubMed ID: 7616537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic carcinoma surveillance in patients with familial melanoma.
    Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
    Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oncogene expression and point mutation in human pancreatic adenocarcinomas].
    Li DC; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):152-5. PubMed ID: 1477938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A syndrome of hereditary pancreatic adenocarcinoma and cysts of the liver and kidneys.
    Gates LK; Holladay DV
    Gastroenterology; 2002 Mar; 122(3):796-9. PubMed ID: 11875013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
    Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
    J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing methods for the diagnosis of pancreatic cancer.
    Brugge WR
    J Clin Gastroenterol; 2007; 41(10):869-70. PubMed ID: 18090153
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gene diagnosis of pancreatic adenocarcinoma].
    Wang ZY; Liu TH; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
    Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial pancreatic cancer.
    Shi C; Hruban RH; Klein AP
    Arch Pathol Lab Med; 2009 Mar; 133(3):365-74. PubMed ID: 19260742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.
    Chappuis PO; Ghadirian P; Foulkes WD
    Cancer Invest; 2001; 19(1):65-75. PubMed ID: 11291558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
    Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
    PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.
    Hengstler JG; Bauer A; Wolf HK; Bulitta CJ; Tanner B; Oesch F; Gebhard S; Boettger T
    Anticancer Res; 2000; 20(5A):2967-74. PubMed ID: 11062709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature.
    Ehrenthal D; Haeger L; Griffin T; Compton C
    Cancer; 1987 May; 59(9):1661-4. PubMed ID: 3828965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited predisposition to pancreatic cancer.
    Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR; Brentnall TA
    Gut; 2001 Feb; 48(2):143-7. PubMed ID: 11156628
    [No Abstract]   [Full Text] [Related]  

  • 18. A family study of adenocarcinoma of the colon and multiple primary cancer.
    Lynch HT; Swartz M; Lynch J; Krush AJ
    Surg Gynecol Obstet; 1972 May; 134(5):781-6. PubMed ID: 5031490
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
    Yan Y; Gao R; Trinh TLP; Grant MB
    Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
    [No Abstract]   [Full Text] [Related]  

  • 20. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.